- Home
- SBET vs STTK Comparison
SBET vs STTK Comparison
Compare SBET & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- STTK
- Stock Information
- Founded
- SBET 1995
- STTK 2016
- Country
- SBET United States
- STTK United States
- Employees
- SBET N/A
- STTK N/A
- Industry
- SBET Computer Software: Prepackaged Software
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- SBET Technology
- STTK Health Care
- Exchange
- SBET Nasdaq
- STTK Nasdaq
- Market Cap
- SBET 38.7M
- STTK 37.6M
- IPO Year
- SBET 1997
- STTK 2020
- Fundamental
- Price
- SBET $9.54
- STTK $0.79
- Analyst Decision
- SBET
- STTK Hold
- Analyst Count
- SBET 0
- STTK 4
- Target Price
- SBET N/A
- STTK $3.00
- AVG Volume (30 Days)
- SBET 12.4M
- STTK 385.8K
- Earning Date
- SBET 08-14-2025
- STTK 07-31-2025
- Dividend Yield
- SBET N/A
- STTK N/A
- EPS Growth
- SBET N/A
- STTK N/A
- EPS
- SBET N/A
- STTK N/A
- Revenue
- SBET $3,428,134.00
- STTK $4,606,000.00
- Revenue This Year
- SBET N/A
- STTK N/A
- Revenue Next Year
- SBET N/A
- STTK N/A
- P/E Ratio
- SBET N/A
- STTK N/A
- Revenue Growth
- SBET N/A
- STTK 69.65
- 52 Week Low
- SBET $2.26
- STTK $0.69
- 52 Week High
- SBET $124.12
- STTK $4.99
- Technical
- Relative Strength Index (RSI)
- SBET 42.02
- STTK 38.78
- Support Level
- SBET $8.70
- STTK $0.85
- Resistance Level
- SBET $12.03
- STTK $1.14
- Average True Range (ATR)
- SBET 4.39
- STTK 0.08
- MACD
- SBET -2.95
- STTK -0.02
- Stochastic Oscillator
- SBET 1.62
- STTK 1.60
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.